Amend Surgical, Inc.

Amend Surgical develops and commercializes novel biocompatible adhesive and barrier technologies for dental, oral surgical, and orthopedic applications. The company's proprietary hydrogel and chitosan-based platforms, licensed from Harvard's Wyss Institute, are designed to adhere and protect tissue in wet, mechanically challenging environments. Amend Tissue Tape™ is a non-resorbable wound and barrier technology that forms long-lasting ionic and covalent bonds for oral surgical applications. Amend Tissure™ is a resorbable adhesive barrier enabling suture-less peripheral nerve repair. Amend Nano Fuse™ combines bioactive glass and demineralized allograft bone for orthopedic and spinal fusion procedures. All products are patent-protected and ISO 13485-certified, with ongoing development of combination products incorporating targeted drug delivery for enhanced regenerative outcomes.